SCHEMBL19322018

SCHEMBL19322018

COc1cc(C)cc(Br)c1O[Si](C)(C)C(C)(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.47
MAPT P10636 8/20 0.39
L3MBTL1 Q9Y468 5/20 0.39
KDM4E B2RXH2 2/20 0.39
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
LMNA P02545 3/20 0.37
ALOX15 P16050 1/20 0.36
ALOX12 P18054 1/20 0.36
NPSR1 Q6W5P4 2/20 0.36
POLB P06746 1/20 0.36
HTT P42858 3/20 0.35
TSHR P16473 1/20 0.35
APOBEC3A P31941 1/20 0.35
APOBEC3G Q9HC16 1/20 0.35
ALDH1A1 P00352 4/20 0.34
HPGD P15428 3/20 0.33
MAPK1 P28482 1/20 0.33
SYK P43405 1/20 0.33
ATM Q13315 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19317226 0.82 NPSR1 (0.35) MAPTL3MBTL1KDM4EALOX15ALOX12
SCHEMBL19354644 0.80 CRHR1 (0.40) MAPTALOX15ALOX12NPSR1POLB
SCHEMBL12766051 0.80 PTGS2 (0.51) MAPTALOX15NPSR1POLBHTT
SCHEMBL30876424 0.78 ALDH1A1 (0.52) MAPTLMNAHTTTSHRALDH1A1
SCHEMBL3686242 0.78 ALDH1A1 (0.52) MAPTLMNAHTTTSHRALDH1A1
SCHEMBL16815975 0.78 SMN1; SMN2 (0.39) ACHEMAPTL3MBTL1KDM4ELMNA
SCHEMBL5089695 0.78 SMN1; SMN2 (0.38) KDM4EPOLBALDH1A1SMN1; SMN2CA2
SCHEMBL31546289 0.78 SMN1; SMN2 (0.39) ACHEMAPTL3MBTL1KDM4ELMNA
SCHEMBL9880773 0.78 ACHE (0.70) ACHEMAPTL3MBTL1KDM4EMAOA
SCHEMBL1421690 0.76 NQO2 (0.38) MAPTKDM4ELMNANPSR1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017155910-A1 THIAZOLIDINONE COMPOUNDS AND USE THEREOF NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2017-09-14 WO disclosed
US-20170253569-A1 THIAZOLIDINONE COMPOUNDS AND USE THEREOF REGENTS OF THE UNIVERSITY OF MINNESOTA 2017-09-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170253569-A1 THIAZOLIDINONE COMPOUNDS AND USE THEREOF OPRL1, OPRD1, OPRK1 ACHE 829/4885MAPT 1648/4885L3MBTL1 4651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.